Texas Institute for Genomic Medicine

The Texas A&M Institute for Genomic Medicine (TIGM) is a research institute of Texas A&M AgriLife Research. It was founded in 2005 under a $50 million award from the Texas Enterprise Fund to pioneer the development of life-changing medical breakthroughs, accelerate the pace of medical discoveries and foster the development of the biotechnology industry in Texas. To that end, TIGM helps researchers gain faster access to the genetically engineered knockout mice they need to help speed research to find the cure for human diseases and conditions. TIGM owns and maintains the world’s largest library of embryonic stem cells for C57BL/6 mice in the world. In addition, TIGM has contracted access to the world’s largest library of genetically modified 129 mouse cells. The Institute headquarters and laboratory facilities are based on the main campus of Texas A&M University in College Station, Texas.[1]

References

  1. ↑ "." Texas A&M Institute for Genomic Medicine.

External links

This article is issued from Wikipedia - version of the 3/23/2013. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.